尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Quynh-Boi Demey, Chief Financial Officer. Director active across 1 company, notably EXOSENS. Aggregated, 2 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €4.5m. Activity tracked since 4 June 2025. The latest transaction was disclosed on 18 March 2026 (Cession). Regulator: AMF. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Quynh-Boi Demey is the Chief Financial Officer of EXOSENS, an industrial technology group listed on the stock market and focused on detection and imaging solutions. She has held this role since April 2022, placing her at the center of financial steering, capital allocation, investor communications, and the broader governance framework of a newly listed company. In practice, she has supported EXOSENS through a key phase of transformation, from strong growth and organizational structuring to life as a public company with regular earnings reporting and shareholder engagement. Before joining EXOSENS, she served as CFO of Saft Group from 2019 to 2022, gaining direct experience in an international industrial environment where operational performance, financial discipline, and investment oversight are critical. She also held senior finance positions at General Electric from 2010 to 2018, and previously worked at Areva T&D as Director of Finance and Management Control in 2009-2010. Earlier in her career, she contributed to post-merger integration and management control at Alcatel Lucent between 2006 and 2009. She began her professional path in consulting with EY, Eurogroup, and PwC. This background reflects a strong command of financial management, integration processes, reporting, and transformation programs. Her career profile is especially well suited to technology-led industrial companies operating globally, where finance must support both growth and operational excellence. A graduate of emlyon business school, she combines technical financial expertise with strategic judgment and stakeholder credibility. At EXOSENS, her responsibilities are particularly important to the company’s financial transparency, balance-sheet optimization, and ability to execute its long-term development strategy in public markets.